Abstract
Urolithiasis is a relatively common problem around the world. In neurologically impaired children and those with cerebral palsy, kidney stones represent an understudied and unique challenge. Children with cerebral palsy are at increased risk of kidney stones due to their limited mobility, associated hypercalciuria, and inability in some to self-regulate their water intake. Some children are exposed to antiepileptic medications that have lithogenic potential, while other children may be receiving a ketogenic diet to help control their epilepsy. Children with cerebral palsy presenting with kidney stones may be unable to verbalize their discomfort and do not have a typical clinical presentation of renal colic, which can cause a delay in the diagnosis and treatment. Conservative management includes analgesia, hydration, and medical expulsive therapy. Surgical treatment of kidney stones is considered for larger stones, patients with persistent pain, and presence of urinary tract infection or urinary tract obstruction. The prevention strategies for recurrence of kidney stones include dietary modification and ample fluid administration. In some cases, alkali therapy and administration of thiazide diuretics may also be helpful.
This is a preview of subscription content, log in via an institution to check access.
References
Andrews PI, Rosenberg AR (1990) Renal consequences of immobilisation in children with fractured femurs. Acta Paediatr Scand 79:311–315
Bartosh SM (2004) Medical management of pediatric stone disease. Urol Clin North Am 31:575–587, x–xi. https://doi.org/10.1016/j.ucl.2004.04.005
Ben-Menachem E, Sander JW, Stefan H, Schwalen S, Schauble B (2008) Topiramate monotherapy in the treatment of newly or recently diagnosed epilepsy. Clin Ther 30:1180–1195
Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346:77–84. https://doi.org/10.1056/NEJMoa010369
Christensen D et al (2014) Prevalence of cerebral palsy, co-occurring autism spectrum disorders, and motor functioning – Autism and Developmental Disabilities Monitoring Network, USA, 2008. Dev Med Child Neurol 56:59–65. https://doi.org/10.1111/dmcn.12268
Copelovitch L (2012) Urolithiasis in children: medical approach. Pediatr Clin N Am 59:881–896. https://doi.org/10.1016/j.pcl.2012.05.009
Corbin Bush N, Twombley K, Ahn J, Oliveira C, Arnold S, Maalouf NM, Sakhaee K (2013) Prevalence and spot urine risk factors for renal stones in children taking topiramate. J Pediatr Urol 9:884–889. https://doi.org/10.1016/j.jpurol.2012.12.005
Eberson CP, Pacicca DM, Ehrlich MG (1999) The role of ketorolac in decreasing length of stay and narcotic complications in the postoperative pediatric orthopaedic patient. J Pediatr Orthop 19:688–692
Faught E (2004) Review of United States and European clinical trials of zonisamide in the treatment of refractory partial-onset seizures. Seizure 13(Suppl 1):S59–S65. https://doi.org/10.1016/j.seizure.2004.04.009; discussion S71-52
Faught E, Ayala R, Montouris GG, Leppik IE (2001) Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures. Neurology 57:1774–1779
Furth SL et al (2000) Risk factors for urolithiasis in children on the ketogenic diet. Pediatr Nephrol (Berlin) 15:125–128
Gnessin E, Mandeville JA, Handa SE, Lingeman JE (2011) Changing composition of renal calculi in patients with musculoskeletal anomalies. J Endourol 25:1519–1523. https://doi.org/10.1089/end.2010.0698
Go T (2013) Zonisamide induces crystalluria without urinary pH changes in children and young adults. ISRN Neurol 2013:841902. https://doi.org/10.1155/2013/841902
Gonzalez A, Smith DP (1998) Minimizing hospital length of stay in children undergoing ureteroneocystostomy. Urology 52:501–504
Goyal M, Grossberg RI, O'Riordan MA, Davis ID (2009) Urolithiasis with topiramate in nonambulatory children and young adults. Pediatr Neurol 40:289–294. https://doi.org/10.1016/j.pediatrneurol.2008.11.004
Greeves RM, Thompson A, Bourke T (2018) Question 1: are alpha-antagonists useful in promoting the passage of renal stones in children? Arch Dis Child 103:806–808. https://doi.org/10.1136/archdischild-2018-315230
Habbig S, Beck BB, Hoppe B (2011) Nephrocalcinosis and urolithiasis in children. Kidney Int 80:1278–1291. https://doi.org/10.1038/ki.2011.336
Heneghan JP, McGuire KA, Leder RA, DeLong DM, Yoshizumi T, Nelson RC (2003) Helical CT for nephrolithiasis and ureterolithiasis: comparison of conventional and reduced radiation-dose techniques. Radiology 229:575–580. https://doi.org/10.1148/radiol.2292021261
Hess B, Zipperle L, Jaeger P (1993) Citrate and calcium effects on Tamm-Horsfall glycoprotein as a modifier of calcium oxalate crystal aggregation. Am J Phys 265:F784–F791. https://doi.org/10.1152/ajprenal.1993.265.6.F784
Jhagroo RA, Wertheim ML, Penniston KL (2016) Alkali replacement raises urinary citrate excretion in patients with topiramate-induced hypocitraturia. Br J Clin Pharmacol 81:131–136. https://doi.org/10.1111/bcp.12751
Korkes F, Segal AB, Heilberg IP, Cattini H, Kessler C, Santili C (2006) Immobilization and hypercalciuria in children. Pediatr Nephrol (Berlin, Germany) 21:1157–1160. https://doi.org/10.1007/s00467-006-0157-8
Kossoff EH, Pyzik PL, Furth SL, Hladky HD, Freeman JM, Vining EP (2002) Kidney stones, carbonic anhydrase inhibitors, and the ketogenic diet. Epilepsia 43:1168–1171
Kuhns LR, Oliver WJ, Christodoulou E, Goodsitt MM (2011) The predicted increased cancer risk associated with a single computed tomography examination for calculus detection in pediatric patients compared with the natural cancer incidence. Pediatr Emerg Care 27:345–350. https://doi.org/10.1097/PEC.0b013e3182132016
Leppik IE et al (1993) Efficacy and safety of zonisamide: results of a multicenter study. Epilepsy Res 14:165–173
Lewis D et al (2009) Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age. Pediatrics 123:924–934. https://doi.org/10.1542/peds.2008-0642
Mahmoud AA, Rizk T, El-Bakri NK, Riaz M, Dannawi S, Al Tannir M (2011) Incidence of kidney stones with topiramate treatment in pediatric patients. Epilepsia 52:1890–1893. https://doi.org/10.1111/j.1528-1167.2011.03245.x
McNally MA, Pyzik PL, Rubenstein JE, Hamdy RF, Kossoff EH (2009) Empiric use of potassium citrate reduces kidney-stone incidence with the ketogenic diet. Pediatrics 124:e300–e304. https://doi.org/10.1542/peds.2009-0217
Mee MJ, Egerton-Warburton D, Meek R (2011) Treatment and assessment of emergency department nausea and vomiting in Australasia: a survey of anti-emetic management. Emerg Med Australas: EMA 23:162–168. https://doi.org/10.1111/j.1742-6723.2011.01386.x
Minevich E, Defoor W, Reddy P, Nishinaka K, Wacksman J, Sheldon C, Erhard M (2005) Ureteroscopy is safe and effective in prepubertal children. J Urol 174:276–279; discussion 279. https://doi.org/10.1097/01.ju.0000161212.69078.e6
Muller CE, Bianchetti M, Kaiser G (1994) Immobilization, a risk factor for urinary tract stones in children. A case report. Eur J Pediatr Surg 4:201–204. https://doi.org/10.1055/s-2008-1066104
Novak I, Hines M, Goldsmith S, Barclay R (2012) Clinical prognostic messages from a systematic review on cerebral palsy. Pediatrics 130:e1285–e1312. https://doi.org/10.1542/peds.2012-0924
Pak CY (1987) Citrate and renal calculi. Miner Electrolyte Metab 13:257–266
Parsons JK, Hergan LA, Sakamoto K, Lakin C (2007) Efficacy of alpha-blockers for the treatment of ureteral stones. J Urol 177:983–987. https://doi.org/10.1016/j.juro.2006.10.023; discussion 987
Sampath A, Kossoff EH, Furth SL, Pyzik PL, Vining EP (2007) Kidney stones and the ketogenic diet: risk factors and prevention. J Child Neurol 22:375–378. https://doi.org/10.1177/0883073807301926
Sato S, Nishinaka K, Takahashi S, Hirobe M, Tsukamoto T (2013) [Bilateral urolithiasis with zonisamide developed for a short period of time in a 10-year-old girl with intractable epilepsy]. Nihon Hinyokika Gakkai Zasshi 104:674–677
Sheth RD (2004) Metabolic concerns associated with antiepileptic medications. Neurology 63:S24–S29
Shokeir AA, Sheir KZ, El-Nahas AR, El-Assmy AM, Eassa W, El-Kappany HA (2006) Treatment of renal stones in children: a comparison between percutaneous nephrolithotomy and shock wave lithotripsy. J Urol 176:706–710. https://doi.org/10.1016/j.juro.2006.03.080
Smith PJ, Basravi S, Schlomer BJ, Bush NC, Brown BJ, Gingrich A, Baker LA (2011) Comparative analysis of nephrolithiasis in otherwise healthy versus medically complex gastrostomy fed children. J Pediatr Urol 7:244–247. https://doi.org/10.1016/j.jpurol.2011.02.018
Stewart AF, Adler M, Byers CM, Segre GV, Broadus AE (1982) Calcium homeostasis in immobilization: an example of resorptive hypercalciuria. N Engl J Med 306:1136–1140. https://doi.org/10.1056/nejm198205133061903
Straub M, Gschwend J, Zorn C (2010) Pediatric urolithiasis: the current surgical management. Pediatr Nephrol (Berlin, Germany) 25:1239–1244. https://doi.org/10.1007/s00467-009-1394-4
Tasian GE, Copelovitch L (2014) Evaluation and medical management of kidney stones in children. J Urol 192:1329–1336. https://doi.org/10.1016/j.juro.2014.04.108
Topamax Package Insert (2009) Janssen pharmaceutical companies. http://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/TOPAMAX-pi.pdf
Van Savage JG, Palanca LG, Anderson RD, Rao GS, Slaughenhoupt BL (2000) Treatment of distal ureteral stones in children: similarities to the american urological association guidelines in adults. J Urol 164(3 Pt 2):1089–1093
Vega D, Maalouf NM, Sakhaee K (2007) Increased propensity for calcium phosphate kidney stones with topiramate use. Expert Opin Drug Saf 6:547–557. https://doi.org/10.1517/14740338.6.5.547
Velazquez N, Zapata D, Wang HH, Wiener JS, Lipkin ME, Routh JC (2015) Medical expulsive therapy for pediatric urolithiasis: systematic review and meta-analysis. J Pediatr Urol 11:321–327. https://doi.org/10.1016/j.jpurol.2015.04.036
Wang RC, Smith-Bindman R, Whitaker E, Neilson J, Allen IE, Stoller ML, Fahimi J (2017) Effect of Tamsulosin on stone passage for ureteral stones: a systematic review and meta-analysis. Ann Emerg Med 69:353–361.e3. https://doi.org/10.1016/j.annemergmed.2016.06.044
Wibisono C, Rowe N, Beavis E, Kepreotes H, Mackie FE, Lawson JA, Cardamone M (2015) Ten-year single-center experience of the ketogenic diet: factors influencing efficacy, tolerability, and compliance. J Pediatr 166:1030–1036.e1. https://doi.org/10.1016/j.jpeds.2014.12.018
Zerwekh JE, Ruml LA, Gottschalk F, Pak CY (1998) The effects of twelve weeks of bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in eleven normal subjects. J Bone Mineral Res 13:1594–1601. https://doi.org/10.1359/jbmr.1998.13.10.1594
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
Araya, C.E., Bani-Hani, A. (2019). Kidney Stones: Risks, Prevention, and Management in Cerebral Palsy. In: Miller, F., Bachrach, S., Lennon, N., O'Neil, M. (eds) Cerebral Palsy. Springer, Cham. https://doi.org/10.1007/978-3-319-50592-3_58-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-50592-3_58-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-50592-3
Online ISBN: 978-3-319-50592-3
eBook Packages: Springer Reference MedicineReference Module Medicine